NCT01970969View on ClinicalTrials.gov

THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring

CompletedOBSERVATIONAL

Enrollment

928

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2017

Conditions

Patients With Symptoms of Cardiac Arrhythmia at Risk for Atrial Fibrillation

Trial Locations (1)

92037

Scripps Clinic, La Jolla

All Listed Sponsors

collaborator

Quest Diagnostics-Nichols Insitute

INDUSTRY

lead

Scripps Translational Science Institute

OTHER

NCT01970969 - THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring | Biotech Hunter | Biotech Hunter